Literature DB >> 18054426

Aberrant expression of selenoproteins in the progression of colorectal cancer.

Yoshiyuki Murawaki1, Hiroyuki Tsuchiya, Takamasa Kanbe, Kenichi Harada, Kazuo Yashima, Kimiyasu Nozaka, Osamu Tanida, Michimori Kohno, Tomoyuki Mukoyama, Eiji Nishimuki, Haruhiko Kojo, Tatsuya Matsura, Kazuhiko Takahashi, Mitsuhiko Osaki, Hisao Ito, Junji Yodoi, Yoshikazu Murawaki, Goshi Shiota.   

Abstract

Since damage to DNA and other cellular molecules by reactive oxygen species ranks high as a major culprit in the onset and development of colorectal cancer, the aim of the present study is to clarify the role of antioxidant seleonoproteins including glutathione peroxidase (GPx), thioredoxin reductase (TXR) and selenoprotein P (SePP), and the effect of oxidative stress on the progression of colorectal cancer. Expression of 14 oxidative stress-related molecules in both tumorous and non-tumorous tissues in 41 patients was examined by immunohistochemistry and Western blot analysis. Expression levels of proteins modified by 4-hydroxy-2-nonenal (4-HNE), malonyldialdehyde (MDA) and 4-hydroxy-2-hexenal (4-HHE), and the positive rate of 8-hydroxy-2'-deoxyguanosine (8-OHdG) in tumorous tissues were much higher than those in non-tumorous tissues. Glutathione (GSH) content in tumor tissues was much lower than that in non-tumorous tissues. Expression level of selenoproteins such as GPx-1, GPx-3, and SePP, which are rapidly degraded during selenium deprivation, was significantly decreased in tumorous tissues, whereas that of GPx-2, which is resistant to selenium deprivation, was increased. Expression of SePP was decreased at stage III and IV, compared to that of stage II. These data suggest that contrasting expression pattern of the antioxidant selenoproteins plays an important role in the progression of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054426     DOI: 10.1016/j.canlet.2007.10.019

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  43 in total

Review 1.  The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities.

Authors:  Zhi Huang; Aaron H Rose; Peter R Hoffmann
Journal:  Antioxid Redox Signal       Date:  2012-01-09       Impact factor: 8.401

Review 2.  Redox biology of the intestine.

Authors:  Magdalena L Circu; Tak Yee Aw
Journal:  Free Radic Res       Date:  2011-09-05

Review 3.  Selenoproteins in colon cancer.

Authors:  Kristin M Peters; Bradley A Carlson; Vadim N Gladyshev; Petra A Tsuji
Journal:  Free Radic Biol Med       Date:  2018-05-22       Impact factor: 7.376

Review 4.  Selenium and inflammatory bowel disease.

Authors:  Avinash K Kudva; Ashley E Shay; K Sandeep Prabhu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-06-04       Impact factor: 4.052

Review 5.  Roles for selenium and selenoprotein P in the development, progression, and prevention of intestinal disease.

Authors:  Sarah P Short; Jennifer M Pilat; Christopher S Williams
Journal:  Free Radic Biol Med       Date:  2018-05-17       Impact factor: 7.376

Review 6.  Cancer metabolism: what we can learn from proteomic analysis by mass spectrometry.

Authors:  Weidong Zhou; Lance A Liotta; Emanuel F Petricoin
Journal:  Cancer Genomics Proteomics       Date:  2012-11       Impact factor: 4.069

7.  Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma.

Authors:  Caitlyn W Barrett; Wei Ning; Xi Chen; Jesse Joshua Smith; Mary K Washington; Kristina E Hill; Lori A Coburn; Richard M Peek; Rupesh Chaturvedi; Keith T Wilson; Raymond F Burk; Christopher S Williams
Journal:  Cancer Res       Date:  2012-12-05       Impact factor: 12.701

Review 8.  Toward understanding success and failures in the use of selenium for cancer prevention.

Authors:  Holger Steinbrenner; Bodo Speckmann; Helmut Sies
Journal:  Antioxid Redox Signal       Date:  2013-03-21       Impact factor: 8.401

Review 9.  Glutathione levels in human tumors.

Authors:  Michael P Gamcsik; Mohit S Kasibhatla; Stephanie D Teeter; O Michael Colvin
Journal:  Biomarkers       Date:  2012-08-20       Impact factor: 2.658

Review 10.  Molecular mechanisms by which selenoproteins affect cancer risk and progression.

Authors:  Pin Zhuo; Alan M Diamond
Journal:  Biochim Biophys Acta       Date:  2009-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.